ZBH

SEC source: 0001062993-23-014478 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,507.66

Underlying: Common Stock · 230.359 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

SEC source: 0001062993-23-014476 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,884.23

Underlying: Common Stock · 187.7 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: The units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

SEC source: 0001062993-23-014477 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,240.903

Underlying: Common Stock · 221.827 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

SEC source: 0001062993-23-014473 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,734.34

Underlying: Common Stock · 93.85 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0001062993-23-014471 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,593.386

Underlying: Common Stock · 93.85 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0001062993-23-014469 · form4.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,471.118

Underlying: Common Stock · 187.7 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0001062993-23-014836 · form4a.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,606.184

Underlying: Common Stock · 106.648 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0001062993-23-014835 · form4a.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,767.836

Underlying: Common Stock · 247.423 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0001062993-23-012905 · form4.xml · derivative · entry 3

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,253

Underlying: Common Stock · 628 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: One-third of the RSUs vested on June 1, 2023. The remaining RSUs vest in equal portions on each of June 1, 2024 and June 1, 2025.

F4 · derivative.expiration_date: One-third of the RSUs vested on June 1, 2023. The remaining RSUs vest in equal portions on each of June 1, 2024 and June 1, 2025.

SEC source: 0001062993-23-012905 · form4.xml · nonDerivative · entry 2

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 481

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-23-012905 · form4.xml · nonDerivative · entry 1

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 678

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 50 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on December 30, 2022.

SEC source: 0001062993-23-011215 · form4.xml · derivative · entry 2

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,883.937

Underlying: Common Stock · 950.779 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

SEC source: 0001062993-23-011215 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,499.536

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 3.274 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-011217 · form4.xml · derivative · entry 2

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,546.937

Underlying: Common Stock · 950.779 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

SEC source: 0001062993-23-011217 · form4.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,283.418

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 18.286 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-011214 · form4.xml · derivative · entry 2

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,104.937

Underlying: Common Stock · 950.779 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

SEC source: 0001062993-23-011214 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,640.49

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 6.978 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-011212 · form4.xml · derivative · entry 2

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,928.937

Underlying: Common Stock · 950.779 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

SEC source: 0001062993-23-011212 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,277.301

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 44.143 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-011211 · form4.xml · derivative · entry 2

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,762.937

Underlying: Common Stock · 950.779 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

SEC source: 0001062993-23-011211 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,520.413

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 20.376 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-011209 · form4.xml · derivative · entry 2

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,614.937

Underlying: Common Stock · 950.779 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

SEC source: 0001062993-23-011209 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,104.418

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 28.223 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-011206 · form4.xml · derivative · entry 2

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,104.937

Underlying: Common Stock · 950.779 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

SEC source: 0001062993-23-011206 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,696.53

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 10.350 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-011208 · form4.xml · derivative · entry 2

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,508.937

Underlying: Common Stock · 950.779 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

SEC source: 0001062993-23-011208 · form4.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,991.958

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 29.842 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-011205 · form4.xml · derivative · entry 2

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,383.937

Underlying: Common Stock · 950.779 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

SEC source: 0001062993-23-011205 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,019.076

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 52.364 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-008501 · form4.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,765.132

Underlying: Common Stock · 213.991 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 19.607 phantom stock units accrued on January 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-008499 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,133.512

Underlying: Common Stock · 106.996 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 7.434 phantom stock units accrued on January 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-008497 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,996.262

Underlying: Common Stock · 106.996 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 3.379 phantom stock units accrued on January 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-008494 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,186.18

Underlying: Common Stock · 213.991 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: The units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 10.920 phantom stock units accrued on January 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-008495 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,466.712

Underlying: Common Stock · 252.898 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 56.837 phantom stock units accrued on January 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-008493 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,733.158

Underlying: Common Stock · 262.625 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 47.819 phantom stock units accrued on January 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-008492 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000.037

Underlying: Common Stock · 243.172 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 21.839 phantom stock units accrued on January 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-008490 · form4.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,462.116

Underlying: Common Stock · 243.172 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 32.201 phantom stock units accrued on January 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-008489 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,576.195

Underlying: Common Stock · 291.806 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 30.335 phantom stock units accrued on January 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-007358 · form4.xml · derivative · entry 4

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,045 shares

Expires 2023-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022.

F4 · derivative.exercise_date: Vested annually over four years in increments of 25% each year, commencing on March 18, 2014.

SEC source: 0001062993-23-007358 · form4.xml · nonDerivative · entry 3

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,671

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022.

F3 · price: Reflects the weighted average price of 3,302 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on March 17, 2023 with sale prices ranging from $124.87 to $125.38 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price.

SEC source: 0001062993-23-007358 · form4.xml · nonDerivative · entry 2

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,973

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022.

F2 · price: Reflects the weighted average price of 19,743 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on March 17, 2023 with sale prices ranging from $123.85 to $124.84 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price.

SEC source: 0001062993-23-007358 · form4.xml · nonDerivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,716

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022.

SEC source: 0001062993-23-006287 · form4.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,625

Underlying: Common Stock · 47,625 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

SEC source: 0001062993-23-006285 · form4.xml · derivative · entry 1

Tornos Ivan · CIK 0001757216 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,315

Underlying: Common Stock · 16,315 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

SEC source: 0001062993-23-006286 · form4.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,680

Underlying: Common Stock · 13,680 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

SEC source: 0001062993-23-006284 · form4.xml · derivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,094

Underlying: Common Stock · 7,094 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

SEC source: 0001062993-23-006282 · form4.xml · derivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,283

Underlying: Common Stock · 6,283 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

SEC source: 0001062993-23-006283 · form4.xml · derivative · entry 1

VAN ZUILEN WILFRED · CIK 0001864818 · Pres, Europe, M. East & Africa

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,486

Underlying: Common Stock · 6,486 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

SEC source: 0001062993-23-006281 · form4.xml · derivative · entry 1

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,270

Underlying: Common Stock · 5,270 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

SEC source: 0001062993-23-006279 · form4.xml · derivative · entry 1

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,824

Underlying: Common Stock · 1,824 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.